All Stories

  1. Dihydroceramide redistribution and vesicular release during N. meningitidis infection in brain endothelial cells
  2. Masked Bisphosphonate Inhibitors of Acid Sphingomyelinase: Improved Cell Penetration and Potency
  3. Sphingolipids associate with the chlamydial nucleoid and mark developmental transitions in Chlamydia trachomatis
  4. A novel rapid host cell entry pathway determines the intracellular fate of Staphylococcus aureus
  5. A novel rapid host cell entry pathway determines the intracellular fate of Staphylococcus aureus
  6. Sphingosine 1-phosphate-driven interplay between neutrophils and endometriotic cells fuels fibrosis in endometriosis: insights into the role of neutrophil extracellular traps
  7. Roles of Ceramide Glucosyltransferase in Controlling Cerebral Microvascular Endothelial Integrity and Angiogenesis Post-Ischemia/Reperfusion
  8. Measles virus reprograms CD4+ T-cell sphingolipid and fatty acid metabolism to facilitate infection
  9. Inhaled sphingosine reduces bronchial Pseudomonas aeruginosa burden during porcine ex vivo lung perfusion and shows tissue delivery in explanted human lungs
  10. Chlamydia-like bacterium Simkania negevensis exploits host sphingolipid salvage pathway and sphingomyelin synthesis during infection
  11. Genotoxicity Studies of Indole-3-carbinol and N-Methoxyindole-3-carbinol—The Effect of Sulphotransferases
  12. Monitoring Sphingomyelin Biosynthesis at Nanoscale Resolution by Expansion Microscopy
  13. Chlamydia trachomatis deploys sphingolipids for genome organisation
  14. Pluripotent stem-cell-based screening uncovers sildenafil as a mitochondrial disease therapy
  15. Kidney disease reprograms microbiome-host signaling to promote heart failure
  16. Secondary bile acid production by gut bacteria promotes Western diet-associated colorectal cancer
  17. Deactivation of ceramide de novo synthesis induces cerebral angiogenesis and microvascular remodeling post-ischemia/reperfusion in mice via mechanisms not predominated by extracellular vesicles
  18. Influence of amitriptyline therapy on T cell phenotype in chronic pain patients
  19. Targeting sphingolipid metabolism: inhibition of neutral sphingomyelinase 2 impairs coronaviral replication organelle formation
  20. Genome-wide identification of modulators of Chlamydia trachomatis parasitophorous vacuole stability highlights an important role for sphingolipid supply
  21. Amitriptyline inhibits Plasmodium development in infected red blood cells by modulating sphingolipid metabolism and glucose uptake
  22. Neisseria meningitidis regulates P-glycoprotein transporter activity in brain endothelial cells via sphingosine 1–phosphate receptor 1
  23. Immune cells in dorsal root ganglia are associated with pruritus in a mouse model of allergic contact dermatitis and co-culture study
  24. Chlamydia trachomatis exploits sphingolipid metabolic pathways during infection of phagocytes
  25. Development of an iPSC-derived immunocompetent skin model for identification of skin sensitizing substances
  26. Altered liver lipidome markedly overlaps with human plasma lipids at diabetes risk and reveals adipose-liver interaction
  27. Development and validation of an LC-MS/MS assay for quantification of fosfomycin in Mueller-Hinton broth for application in profiling antibacterial efficacy against clinical bacterial isolates
  28. Sphingosine kills Mycobacteria and suppresses mycobacterial lung infections
  29. Psychosomatic - psychotherapeutic treatment of stress-related disorders impacts the sphingolipid metabolism towards increased sphingosine and sphingosine-1-phosphate levels
  30. Circulating Extracellular Vesicles as Putative Mediators of Cardiovascular Disease in Paediatric Chronic Kidney Disease
  31. Acid sphingomyelinase activity suggests a new antipsychotic pharmaco-treatment strategy for schizophrenia
  32. Lebendzell‐Identifizierung von Inhibitoren des Lipid‐Transfer Proteins CERT Mithilfe von Nanoluciferase Bioluminescence Resonance Energy Transfer (NanoBRET)
  33. Live‐Cell Identification of Inhibitors of the Lipid Transfer Protein CERT Using Nanoluciferase Bioluminescence Resonance Energy Transfer (NanoBRET)
  34. The sphingosine kinase 2 inhibitors ABC294640 and K145 elevate (dihydro)sphingosine 1-phosphate levels in various cells
  35. Metformin modulates microbiota and improves blood pressure and cardiac remodeling in a rat model of hypertension
  36. Transcriptomics pave the way into mechanisms of cobalt and nickel toxicity: Nrf2-mediated cellular responses in liver carcinoma cells
  37. Trifunctional sphingomyelin derivatives enable nanoscale resolution of sphingomyelin turnover in physiological and infection processes via expansion microscopy
  38. The Candida albicans quorum-sensing molecule farnesol alters sphingolipid metabolism in human monocyte-derived dendritic cells
  39. Dynamic changes in the proximitome of neutral sphingomyelinase-2 (nSMase2) in TNFα stimulated Jurkat cells
  40. Gut dysbiosis contributes to TMAO accumulation in CKD
  41. Caveolin-1 affects early mycobacterial infection and apoptosis in macrophages and mice
  42. Dissecting Acute Drug‐Induced Hepatotoxicity and Therapeutic Responses of Steatotic Liver Disease Using Primary Mouse Liver and Blood Cells in a Liver‐On‐A‐Chip Model
  43. Acid ceramidase expression reduces IFNγ secretion by mouse CD4+ T cells and is crucial for maintaining B-cell numbers in mice
  44. Degradation of hexosylceramides is required for timely corpse clearance via formation of cargo-containing phagolysosomal vesicles
  45. Fertilization by short-term stored sperm alters DNA methylation patterns at single-base resolution in common carp (Cyprinus carpio) embryos
  46. Formation of DNA Adducts by 1-Methoxy-3-indolylmethylalcohol, a Breakdown Product of a Glucosinolate, in the Mouse: Impact of the SULT1A1 Status—Wild-Type, Knockout or Humanised
  47. The Role of Neutral Sphingomyelinase-2 (NSM2) in the Control of Neutral Lipid Storage in T Cells
  48. Plant defensive responses to insect eggs are inducible by general egg-associated elicitors
  49. Topical Delivery of Tofacitinib in Dermatology: The Promise of a Novel Therapeutic Class Using Biodegradable Dendritic Polyglycerol Sulfates
  50. Sphingosine kinase 1/S1P receptor signaling axis is essential for cellular uptake of Neisseria meningitidis in brain endothelial cells
  51. Urinary Excretion of Mercapturic Acids of the Rodent Carcinogen Methyleugenol after a Single Meal of Basil Pesto: A Controlled Exposure Study in Humans
  52. Follicular Delivery of Caffeine from a Shampoo for Hair Retention
  53. Aging of common carp (Cyprinus carpio L.) sperm induced by short-term storage does not alter global DNA methylation and specific histone modifications in offspring
  54. Development of Comorbid Depression after Social Fear Conditioning in Mice and Its Effects on Brain Sphingolipid Metabolism
  55. New Therapeutic Options in Pulmonal Diseases: Sphingolipids and Modulation of Sphingolipid Metabolism
  56. Efficient skin interactions of graphene derivatives: challenge, opportunity or both?
  57. Sphingosine as a New Antifungal Agent against Candida and Aspergillus spp.
  58. Cell-intrinsic ceramides determine T cell function during melanoma progression
  59. Antiviral and Anti-Inflammatory Activities of Fluoxetine in a SARS-CoV-2 Infection Mouse Model
  60. The acid ceramidase/ceramide axis controls parasitemia in Plasmodium yoelii-infected mice by regulating erythropoiesis
  61. Cell-intrinsic ceramides determine T cell function during melanoma progression
  62. Biodegradable core-multishell nanocarrier: Topical tacrolimus delivery for treatment of dermatitis
  63. Stbd1-deficient mice display insulin resistance associated with enhanced hepatic ER-mitochondria contact
  64. Stress induces major depressive disorder by a neutral sphingomyelinase 2-mediated accumulation of ceramide-enriched exosomes in the blood plasma
  65. Acid sphingomyelinase deactivation post-ischemia promotes brain angiogenesis and remodeling by small extracellular vesicles
  66. Inflammation in Children with CKD Linked to Gut Dysbiosis and Metabolite Imbalance
  67. Synthesis and Characterization of Ceramide-Containing Liposomes as Membrane Models for Different T Cell Subpopulations
  68. Ceramide levels in blood plasma correlate with major depressive disorder severity and its neutralization abrogates depressive behavior in mice
  69. Antimicrobial effects of inhaled sphingosine against Pseudomonas aeruginosa in isolated ventilated and perfused pig lungs
  70. CFTR modulator therapy alters plasma sphingolipid profiles in people with cystic fibrosis
  71. Mitochondrial Kv1.3 Channels as Target for Treatment of Multiple Myeloma
  72. The glucose transporter GLUT3 controls T helper 17 cell responses through glycolytic-epigenetic reprogramming
  73. S1P Signalling Axis Is Necessary for Adiponectin-Directed Regulation of Electrophysiological Properties and Oxidative Metabolism in C2C12 Myotubes
  74. A versatile high-performance LC-MS/MS assay for the quantification of voriconazole and its N-oxide metabolite in small sample volumes of multiple human matrices for biomedical applications
  75. COVID-19 and its clinical severity are associated with alterations of plasma sphingolipids and enzyme activities of sphingomyelinase and ceramidase
  76. Mouse Liver Compensates Loss of Sgpl1 by Secretion of Sphingolipids into Blood and Bile
  77. Inhaled sphingosine has no adverse side effects in isolated ventilated and perfused pig lungs
  78. Sphingolipids: Effectors and Achilles Heals in Viral Infections?
  79. Nuclear Sphingosine-1-phosphate Lyase Generated ∆2-hexadecenal is A Regulator of HDAC Activity and Chromatin Remodeling in Lung Epithelial Cells
  80. Sphingosine 1-phosphate metabolism and insulin signaling
  81. Epigenetic DNA Methylation of EBI3 Modulates Human Interleukin-35 Formation via NFkB Signaling: A Promising Therapeutic Option in Ulcerative Colitis
  82. Central Acting Hsp10 Regulates Mitochondrial Function, Fatty Acid Metabolism, and Insulin Sensitivity in the Hypothalamus
  83. Inhibition of acid sphingomyelinase increases regulatory T cells in humans
  84. Click-correlative light and electron microscopy (click-AT-CLEM) for imaging and tracking azido-functionalized sphingolipids in bacteria
  85. Azidosphinganine enables metabolic labeling and detection of sphingolipid de novo synthesis
  86. Burn Injury Impairs Neutrophil Chemotaxis Through Increased Ceramide
  87. Acid Sphingomyelinase Impacts Canonical Transient Receptor Potential Channels 6 (TRPC6) Activity in Primary Neuronal Systems
  88. Liposomal FRET Assay Identifies Potent Drug‐Like Inhibitors of the Ceramide Transport Protein (CERT)
  89. Neutral Sphingomyelinase is an Affective Valence-Dependent Regulator of Learning and Memory
  90. Serine Protease-Mediated Cutaneous Inflammation: Characterization of an Ex Vivo Skin Model for the Assessment of Dexamethasone-Loaded Core Multishell-Nanocarriers
  91. The Forebrain-Specific Overexpression of Acid Sphingomyelinase Induces Depressive-Like Symptoms in Mice
  92. A Role of Sphingosine in the Intracellular Survival of Neisseria gonorrhoeae
  93. Immunity-related GTPase induces lipophagy to prevent excess hepatic lipid accumulation
  94. Acid ceramidase of macrophages traps herpes simplex virus in multivesicular bodies and protects from severe disease
  95. Characterization of the small molecule ARC39, a direct and specific inhibitor of acid sphingomyelinase in vitro
  96. S1P and Plasmalogen Derived Fatty Aldehydes in Cellular Signaling and Functions
  97. A photocaged inhibitor of acid sphingomyelinase
  98. Clinical Development of Sphingosine as Anti-Bacterial Drug: Inhalation of Sphingosine in Mini Pigs has no Adverse Side Effects
  99. Acid Sphingomyelinase Deficiency Ameliorates Farber Disease
  100. The Role of Chemoprophylactic Agents in Modulating Platelet Aggregability After Traumatic Brain Injury
  101. Role of Neutral Sphingomyelinase-2 (NSM 2) in the Control of T Cell Plasma Membrane Lipid Composition and Cholesterol Homeostasis
  102. Monitoring the Sphingolipid de novo Synthesis by Stable-Isotope Labeling and Liquid Chromatography-Mass Spectrometry
  103. Use of Acid Ceramidase and Sphingosine Kinase Inhibitors as Antiviral Compounds Against Measles Virus Infection of Lymphocytes in vitro
  104. Vitamin C in combination with inhibition of mutant IDH1 synergistically activates TET enzymes and epigenetically modulates gene silencing in colon cancer cells
  105. Acid sphingomyelinase – a regulator of canonical transient receptor potential channel 6 (TRPC6) activity
  106. Dermal Delivery of the High-Molecular-Weight Drug Tacrolimus by Means of Polyglycerol-Based Nanogels
  107. Sphingosine-coating of plastic surfaces prevents ventilator-associated pneumonia
  108. Intestinal Acid Sphingomyelinase Protects From Severe Pathogen-Driven Colitis
  109. Measles Virus Infection Fosters Dendritic Cell Motility in a 3D Environment to Enhance Transmission to Target Cells in the Respiratory Epithelium
  110. Identification of functional lipid metabolism biomarkers of brown adipose tissue aging
  111. Qualifying X-ray and Stimulated Raman Spectromicroscopy for Mapping Cutaneous Drug Penetration
  112. 1-Methoxy-3-indolylmethyl DNA adducts in six tissues, and blood protein adducts, in mice under pak choi diet: time course and persistence
  113. Core-multishell nanocarriers enhance drug penetration and reach keratinocytes and antigen-presenting cells in intact human skin
  114. Methionine restriction prevents onset of type 2 diabetes in NZO mice
  115. Fibroblast origin shapes tissue homeostasis, epidermal differentiation, and drug uptake
  116. Interleukin-22 protects intestinal stem cells against genotoxic stress
  117. Antidepressants regulate autophagy by targeting acid sphingomyelinase
  118. Ventilator-induced lung injury is aggravated by antibiotic mediated microbiota depletion in mice
  119. Pathological manifestations of Farber disease in a new mouse model
  120. Vitamin C promotes decitabine or azacytidine induced DNA hydroxymethylation and subsequent reactivation of the epigenetically silenced tumour suppressor CDKN1A in colon cancer cells
  121. Antidepressants act by inducing autophagy controlled by sphingomyelin–ceramide
  122. Down‐regulation of acid sphingomyelinase and neutral sphingomyelinase‐2 inversely determines the cellular resistance to plasmalemmal injury by pore‐forming toxins
  123. Arsenic-containing hydrocarbons: effects on gene expression, epigenetics, and biotransformation in HepG2 cells
  124. Sphingosine Kinase 1 Regulates Inflammation and Contributes to Acute Lung Injury in Pneumococcal Pneumonia via the Sphingosine-1-Phosphate Receptor 2
  125. How Effective Is Tacrolimus in the Imiquimod-Induced Mouse Model of Psoriasis?
  126. Synthesis of poly(lactide-co-glycerol) as a biodegradable and biocompatible polymer with high loading capacity for dermal drug delivery
  127. Enhanced topical delivery of dexamethasone by β-cyclodextrin decorated thermoresponsive nanogels
  128. Selenium increases hepatic DNA methylation and modulates one-carbon metabolism in the liver of mice
  129. Enhanced Acid Sphingomyelinase Activity Drives Immune Evasion and Tumor Growth in NSCL Carcinoma.
  130. The sphingosine 1-phosphate breakdown product, (2 E )-hexadecenal, forms protein adducts and glutathione conjugates in vitro
  131. Formulation and ex vivo evaluation of polymeric nanoparticles for controlled delivery of corticosteroids to the skin and the corneal epithelium
  132. Biocompatibility and characterization of polyglycerol-based thermoresponsive nanogels designed as novel drug-delivery systems and their intracellular localization in keratinocytes
  133. Lysophosphatidic Acid Inhibits Insulin Signaling in Primary Rat Hepatocytes via the LPA3 Receptor Subtype and is Increased in Obesity
  134. Ethyl cellulose nanocarriers and nanocrystals differentially deliver dexamethasone into intact, tape-stripped or sodium lauryl sulfate-exposed ex vivo human skin - assessment by intradermal microdialysis and extraction from the different skin layers
  135. In SilicoPrediction of Human Sulfotransferase 1E1 Activity Guided by Pharmacophores from Molecular Dynamics Simulations
  136. Highly sensitive isotope-dilution liquid-chromatography–electrospray ionization–tandem-mass spectrometry approach to study the drug-mediated modulation of dopamine and serotonin levels in Caenorhabditis elegans
  137. Glucosinolates Are Mainly Absorbed Intact in Germfree and Human Microbiota-Associated Mice
  138. The glucosinolate metabolite 1-methoxy-3-indolylmethyl alcohol induces a gene expression profile in mouse liver similar to the expression signature caused by known genotoxic hepatocarcinogens
  139. Loss of pdr-1/parkin influences Mn homeostasis through altered ferroportin expression in C. elegans
  140. Simultaneous Detection of Multiple DNA Adducts in Human Lung Samples by Isotope-Dilution UPLC-MS/MS
  141. Method to Simultaneously Determine the Sphingosine 1-Phosphate Breakdown Product (2E)-Hexadecenal and Its Fatty Acid Derivatives Using Isotope-Dilution HPLC–Electrospray Ionization–Quadrupole/Time-of-Flight Mass Spectrometry
  142. A secondary metabolite of Brassicales, 1-methoxy-3-indolylmethyl glucosinolate, as well as its degradation product, 1-methoxy-3-indolylmethyl alcohol, forms DNA adducts in the mouse, but in varying tissues and cells
  143. Optimized enzymatic hydrolysis of DNA for LC–MS/MS analyses of adducts of 1-methoxy-3-indolylmethyl glucosinolate and methyleugenol
  144. Abundance of DNA adducts of methyleugenol, a rodent hepatocarcinogen, in human liver samples
  145. Detection of DNA Adducts Originating from 1-Methoxy-3-indolylmethyl Glucosinolate Using Isotope-Dilution UPLC-ESI-MS/MS
  146. 1-Methoxy-3-indolylmethyl glucosinolate; a potent genotoxicant in bacterial and mammalian cells: Mechanisms of bioactivation